Filo Project up for hero award

The Filo Project, which provides a special form of dementia day care for 350 clients across Devon, Somerset and East Lancashire, is up for an Alzheimer’s Society Dementia Hero Award today.  The Dementia Hero Awards on 28 April honour organisations and individuals who do life-changing work in dementia care.  In the Filo Project, “hosts” provide day care in their own homes to small groups of socially isolated older people with mild to moderate dementia.   “We’re delighted the Filo Project is in the finals of the national Alzheimer’s Society Dementia Hero Awards,” said Libby Price, Filo Project co-director.  “Whatever the outcome on the day, this speaks to the commitment, skill and enthusiasm of our hard-working hosts and colleagues, and the tangible impact of a Filo day.”

Libby Price

Similar Posts

  • Right to end-of-life care

    Dying people’s right to health care has been made explicit in law for the first time under new government plans for England.  Alongside the government announcement, end of life charity Marie Curie released figures showing that around 215,000 people miss out on end-of-life care every year.  Baroness Illora Finlay described the change in the law,…

  • Dementia and cancer

    Alzheimer’s Society has teamed up with Leeds Beckett University to create an online forum dedicated to supporting family carers of people affected by both dementia and cancer. “Through the forum we want to provide carers of people with dementia and cancer with a social support network of others who understand the unique challenges they may…

  • Vitamin D

    Taking vitamin D supplements is associated with a lower risk of dementia, a large-scale study conducted by Calgary and Exeter universities has found. Researchers explored the relationship between vitamin D dietary supplements and dementia among more than 12,000 US participants, finding that taking the vitamin appeared in result in living dementia-free for longer and a…

  • Home from hospital

    A blueprint to help more people go home from hospital and regain their independence has been produced by the National Care Forum (NCF), which represents non-profit care providers.  Designed to support the NHS’s new intermediate care framework, the NCF blueprint advocates and describes effective accommodation-based intermediate care and reablement.  Published in partnership with the Care…

  • New drugs

    New results from the final stage of extensive clinical trials for the anti-amyloid immunotherapy drug “donanemab” have confirmed significant benefits for people in the early stage of Alzheimer’s disease. The drug, which was shown to slow cognitive and functional decline by 22%, could receive regulatory approval for use in the USA by the end of…